跳至主要内容
临床试验/CTRI/2021/06/034142
CTRI/2021/06/034142尚未招募未知

An open-label, randomized, comparative study of the preventive efficacy and safety of Asmidine Spray, metered-dose inhaler versus Salbutamol, metered-dose inhaler, in patients with partially controlled asthma.

VITROBIO SAS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
VITROBIO SAS

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Signed Informed consent form for participation in the clinical study.
  • 2 6.Forced expiratory volume - 1 second (FEV1) before the use of broncholytics not less than 60% of proper value (at screening visit or at the moment of test within 30 days before screening visit).
  • 3 Positive result of the test for reversibility of airway obstruction, expressed as Î?FEV1 >=12% and >=200 ml vs.

排除标准

  • 1 Diagnosis of COPD, established according to the GOLD guidelines, ver. 2018.
  • 2 6.Conditions requiring the use of systemic GCS at the time of the screening visit.
  • 3.Unexpected and progressive deterioration of control of symptoms of BA.
  • 4.Unstable course of bronchial asthma, hospitalization due to exacerbation of bronchial asthma in the intensive care unit using intubation, frequent exacerbations of asthma
  • 5.Pulmonary tuberculosis (active or inactive form).
  • 6. covid positve

研究者

发起方
VITROBIO SAS

相似试验

preventive efficacy and safety of Asmidine Spray,... | 临床试验